(2025). Baricitinib Combination Therapy Demonstrates Significant Improvement in Cardiac Conduction Defects in Rapidly Progressive Systemic Sclerosis: A Case Report. Open Access Rheumatology: Research and Reviews.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Baricitinib Combination Therapy Demonstrates Significant Improvement in Cardiac Conduction Defects in Rapidly Progressive Systemic Sclerosis: A Case Report."
Open Access Rheumatology: Research and Reviews 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Baricitinib Combination Therapy Demonstrates Significant Improvement in Cardiac Conduction Defects in Rapidly Progressive Systemic Sclerosis: A Case Report."
Open Access Rheumatology: Research and Reviews, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.